Report reveals that the cellular immunotherapy landscape continues to expand, with 472 more cellular therapies in development now than one year ago.
Results of recent survey of clinical trial investigators in United States, Europe, and Asia together with analysis of ongoing clinical trials conducted by IQVIA published in Nature Reviews Drug Discovery.
The American Association for Cancer Research (AACR) will present Steven A. Rosenberg, MD, PhD, Fellow of the AACR Academy, with the 2020 AACR-CRI Lloyd J. Old Award in Cancer Immunology.
Updated report on trends in global PD-1/PD-L1 immunotherapy clinical development from the Cancer Research Institute published in Nature Reviews Drug Discovery.
Cancer Research Institute leverages data from GlobalData’s Pharma Intelligence platform in an immuno-oncology landscape update.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Terence Friedlander, M.D., answers questions about immunotherapy for bladder cancer from the 2020 CRI Virtual Immunotherapy Patient Summit.
Dr. Elizabeth Jaffee answers questions on immunotherapy for pancreatic cancer from the 2020 CRI Virtual Immunotherapy Patient Summit.